Exclusive access to Samsung’s research platform enables protocol-aligned biosensor data capture, raw signal access, and end-to-end study execution, setting a new standard for wearable-based clinical evidence generation.
Новина
Huma and Samsung Announce Partnership to Advance Biomarker Development and Clinical Endpoints from Early-Phase Research to Real- World Evidence
· Huma
